Abstract
Microbial exopolysaccharides, particularly scleroglucan and schizophyllan, have shown outstanding potential for use in food and medical/pharmaceutical industries. Scleroglucan and schizophyllan are obtained from fungal sources and their exclusive physico-chemical attributes offer a wide range of applications as stabilizers, gelling agents, thickeners, carriers of nutraceuticals, drugs and other bioactive compounds, prebiotics, immunostimulants, immunomodulators, antimicrobial and antiviral agents, hypoglycemic and hypocholesterolemic substances, and excipients. Additionally, several potential applications of these exopolysaccharides are yet to be explored for the development of functional foods and commercial pharmaceuticals. This chapter provides a comprehensive overview about the structural description, sources, physicochemical properties, production, isolation, and recovery of scleroglucan and schizophyllan. Moreover, potential applications of these exopolysaccharides for the development of functional foods, edible coatings and delivery systems for drugs, nutraceuticals, and bioactive substances have been discussed in detail. Furthermore, various health-promoting aspects of scleroglucan and schizophyllan in controlling lifestyle-related disorders (hyperglycemia and hypercholesterolemia) have also been conversed in this treatise.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ates O. Systems biology of microbial exopolysaccharides production. Front Bioeng Biotechnol. 2015;3:200.
Banerjee S, Parasramka M, Paruthy SB. Polysaccharides in cancer prevention: from bench to bedside. In: Ramawat KG, Mérillon JM, editors. Polysaccharides: bioactivity and biotechnology. Cham: Springer International Publishing; 2015. p. 2179–214.
Bermejo-Jambrina M, Eder J, Helgers LC, et al. C-type lectin receptors in antiviral immunity and viral escape. Front Immunol. 2018;9:590. https://doi.org/10.3389/fimmu.2018.00590.
Brigand G. Scleroglucan. In: Whistler RL, Bemiller JN, editors. Industrial gums: polysaccharides and their derivatives. San Diego: Academic; 2012. p. 461–74.
Chen L, Liu X, Wong KH. Novel nanoparticle materials for drug/food delivery-polysaccharides. Phys Sci Rev. 2016;2016(8):201653. https://doi.org/10.1515/psr-2016-0053.
Corrente F, Paolicelli P, Matricardi P, et al. Novel pH-sensitive physical hydrogels of carboxymethyl scleroglucan. J Pharm Sci. 2012;101(1):256–67. https://doi.org/10.1002/jps.22766.
Dave VS. QbD considerations for excipient manufacturing. In: Beg S, Hasnain MS, editors. Pharmaceutical quality by design: principles and applications. New Delhi: Academic; 2019. p. 65–76.
El Asjadi S, Nederpel QA, Cotiuga IM, et al. Biopolymer scleroglucan as an emulsion stabilizer. Colloids Surf A Physicochem Eng Asp. 2018;546:326–33. https://doi.org/10.1016/j.colsurfa.2018.02.035.
Farina JI, Sineriz F, Molina OE, et al. Determination of radial growth rate of colonies of Sclerotium rolfsii F-6656 for the evaluation of culture medium, optimum incubation temperature, osmo- and halotolerance. Rev Arg Microbiol. 1996;28:190–6.
Farina JI, Sineriz F, Molina OE, et al. Isolation and physicochemical characterization of soluble scleroglucan from Sclerotium rolfsii – rheological properties, molecular weight and conformational characteristics. Carbohydr Polym. 2001;44:41–50.
Freitas F, Roca C, Reis MA. Fungi as sources of polysaccharides for pharmaceutical and biomedical applications. In: Thakur VK, Thakur MK, editors. Handbook of polymers for pharmaceutical technologies. Volume 3, Biodegradable polymers. Hoboken/Beverly: Scrivener Publishing LLC/Wiley; 2015. p. 61–103.
Gao C. Application of a novel biopolymer to enhance oil recovery. J Petrol Explor Prod Technol. 2016;6:749–53. https://doi.org/10.1007/s13202-015-0213-7.
Giavasis I. Production of microbial polysaccharides for use in food. In: McNeil B, Archer D, Giavasis I, et al., editors. Microbial production of food ingredients, enzymes, and nutraceuticals. Cambridge: Woodhead Publishing; 2013. p. 413–68.
Giavasis I. Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals. Curr Opin Biotechnol. 2014;26:162–73. https://doi.org/10.1016/j.copbio.2014.01.010.
Giridharan S, Srinivasan M. Mechanisms of NF-κB p65 and strategies for therapeutic manipulation. J Inflamm Res. 2018;11:407–19.
Goff HD, Guo Q. The role of hydrocolloids in the development of food structure. In: Spyropoulos F, Lamidis A, Norton IT, editors. Handbook of food structure development. Wales: The Royal Society of Chemistry; 2019. p. 1–28.
Jindal N, Khattar JS. Microbial polysaccharides in food industry. In: Grumezescu AM, Holban AM, editors. Handbook of food bioengineering. Volume 20, Biopolymers for food design. London: Academic; 2018. p. 67–85.
Kour D, Rana KL, Kaur T, et al. Extremophiles for hydrolytic enzymes productions: biodiversity and potential biotechnological applications. In: Molina G, Gupta VK, Singh BN, et al., editors. Bioprocessing for biomolecules production. Hoboken: Wiley; 2020. p. 321–56.
Ladrat CD, Sinquin C, Lebellenger L, et al. Exopolysaccharides produced by marine bacteria and their applications as glycosaminoglycan-like molecules. Front Chem. 2014;2:85.
Lembre P, Lorentz C, Martino PD. Exopolysaccharides of the biofilm matrix: a complex biophysical world. In: Karunaratne DN, editor. The complex world of polysaccharides. Rijeka: Intech; 2012. p. 371–92.
Lemieszek M, Rzeski W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp Oncol. 2012;16(4):285–9. https://doi.org/10.5114/wo.2012.30055.
Li P, Harding SE, Liu Z. Cyanobacterial exopolysaccharides: their nature and potential biotechnological applications. Biotechnol Genet Eng Rev. 2001;18:375–404.
Liang K, Han P, Chen Q, et al. Comparative study on enhancing oil recovery under high temperature and high salinity: polysaccharides versus synthetic polymer. ACS Omega. 2019;4(6):10620–8. https://doi.org/10.1021/acsomega.9b00717.
Madhuri KV, Prabhakar KV. Microbial exopolysaccharides: biosynthesis and potential applications. Orient J Chem. 2014;30:1401–10.
Milani J, Maleki G. Hydrocolloids in food industry. In: Valdez B, editor. Food industrial processes – methods and equipment. Rijeka: Intech; 2012. p. 17–38.
Mishra A, Jha B. Microbial exopolysaccharides. In: Rosenberg E, DeLong EF, Lory S, et al., editors. The prokaryotes. Berlin/Heidelberg: Springer; 2013.
Moscovici M. Present and future medical applications of microbial exopolysaccharides. Frontiers in Microbiology, 2015;6(1012).
Nie H, Zheng Y, Li R, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med. 2013;19(3):322–8.
Paolicelli P, Varani G, Pacelli S, et al. Design and characterization of a biocompatible physical hydrogel based on scleroglucan for topical drug delivery. Carbohydr Polyme. 2017;174:960–9.
Patel AK, Michaud P, Singhania RR, et al. Polysaccharides from probiotics: new developments as food additives. Food Technol Biotechnol. 2010;48:451–63.
Plotkin LI, Bivi N. Local regulation of bone cell function. In: Burr DB, Allen MR, editors. Basic and applied bone biology. San Diego: Academic; 2014. p. 47–73.
Rakhra G, Jaiswal SM, Rakhra G. Bioactive peptides and carbohydrates from natural products: a source of functional foods and nutraceuticals. In: Singh J, Meshram V, Gupta M, editors. Bioactive natural products in drug delivery. Singapore: Springer Nature; 2020. p. 335–54.
Rau U. Production of schizophyllan. In: Bucke C, editor. Carbohydrate biotechnology protocols. Totowa: Humana Press; 2008.
Schepetkin, Igor A., and Mark T. Quinn. “Immunomodulatory effects of botanical polysaccharides.” Polysaccharides in medicinal and pharmaceutical applications 35(2011):988–94.
Selvi SS, Eminagic E, Kandur MY, et al. Research and production of microbial polymers for food industry. In: Molina G, Gupta VK, Singh BN, et al., editors. Bioprocessing for biomolecules production. Hoboken: Wiley; 2020. p. 225–6.
Shamtsyan M. Potential to develop functional food products from mushroom bioactive compounds. J Hyg Eng Des. 2016;15:51–9.
Shit SC, Shah PM. Edible polymers: challenges and opportunities. J Polym. 2014;2014:1–13.
Smelcerovic A, Knezevic-Jugovic Z, Petronijevic Z. Microbial polysaccharides and their derivatives as current and prospective pharmaceuticals. Curr Pharm Des. 2008;14:3168–95.
Survase SA, Saudagar PS, Bajaj IB, et al. Scleroglucan: fermentative production, downstream processing and applications. Food Technol Biotechnol. 2007a;45:107–18.
Survase SA, Saudagar PS, Singhal RS. Enhanced production of scleroglucan by Sclerotium rolfsii MTCC 2156 by use of metabolic precursors. Bioresour Technol. 2007b;98:410–5.
Sutivisedsak N, Leathers TD, Price NP. Production of schizophyllan from distiller’s dried grains with solubles by diverse strains of Schizophyllum commune. Springerplus. 2013;2:476. https://doi.org/10.1186/2193-1801-2-476.
Takedatsu H, Mitsuyama K, Mochizuki S, et al. A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. Mol Ther: J Am Soc Gene Therapy. 2012;20(6):1234–41.
Taurhesia S, McNeil B. Physicochemical factors affecting formation of biological response modifier scleroglucan. J Chem Technol Biotechnol. 1994;59:157–63.
Venugopal V. Polysaccharides: their characteristics and marine sources. Marine polysaccharides food applications. Boca Raton: CRC Press; 2011. p. 3–27.
Verma MS, Gu FX. 1,3-β-glucans: drug delivery and pharmacology. In: Karunaratne DN, editor. The complex world of polysaccharides. IntechOpen; 2012.
Vetvicka V, Vannucci L, Sima P. β-glucan as a new tool in vaccine development. Scandinavian. J Immunol. 2020;91(2):e12833. https://doi.org/10.1111/sji.12833.
Wang Y, McNeil B. Effect of temperature on scleroglucan synthesis and organic acid production by Sclerotium glucanicum. Enzym Microb Technol. 1995a;17:893–9.
Wang Y, McNeil B. pH effects on exopolysaccharide and oxalic acid production in cultures of Sclerotium glucanicum. Enzym Microb Technol. 1995b;17:124–30.
Wong JH, Ng TB, Chan HHL, et al. Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials. Appl Microbiol Biotechnol. 2020;104:4675–703.
Wüstenberg T. General overview of food hydrocolloids. In: Wüstenberg T, editor. Cellulose and cellulose derivatives in the food industry – fundamentals and applications. Weinheim: Wiley-VCH; 2015. p. 1–68.
Zhang Z, Zhang F, Liu Y. Recent advances in enhancing the sensitivity and resolution of capillary electrophoresis. J Chromatogr Sci. 2013a;51:666–83.
Zhang Y, Kong H, Fang Y, et al. Schizophyllan: a review on its structure, properties, bioactivities and recent developments. Bioact Carbohydr Diet Fiber I. 2013b;2013:53–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Rahman, H.U.u., Asghar, W., Khalid, N. (2022). Scleroglucan and Schizophyllan. In: Oliveira, J.M., Radhouani, H., Reis, R.L. (eds) Polysaccharides of Microbial Origin. Springer, Cham. https://doi.org/10.1007/978-3-030-42215-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-42215-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42214-1
Online ISBN: 978-3-030-42215-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences